Iopamed

Quick links to important sections

Iopamed

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Iopamed

Quick Facts

Property Description
Active Ingredient Iopamidol (INN)
Form Sterile Aqueous Solution
Pharmacological Class Iodinated Contrast Medium
General Purpose Diagnostic Imaging Enhancement
Origin/Type Synthetic Non-ionic Monomer

What Kind of Diagnostic Agent is Iopamed?

Iopamed is a prescription-only diagnostic agent and is categorically defined as a Radiopaque Medium, serving a strictly visual role in diagnostics rather than a therapeutic function. Its composition, based on Iopamidol, places it in the specialized group of Non-ionic Contrast Media. Iopamed’s distinction lies in its use of the established Iopamidol molecule, which is widely recognized for its efficacy and relatively favorable profile compared to older, ionic contrast types.

Its primary function is to facilitate diagnostic imaging, enabling clinicians to obtain clearer visualizations of internal structures during procedures like angiography or CT scans. Iopamidol is used to enhance the clarity of radiographic images of the brain, spinal cord, heart, blood vessels, and urinary tract. This use confirms its fundamental role as an essential visual aid in complex diagnostic processes.


Composition and Form: The Non-Ionic Iopamidol Solution

The core of Iopamed is the single active ingredient, Iopamidol, a synthetic compound administered as a sterile aqueous solution. Chemically, it is classified as a non-ionic monomer, a type characterized by its low osmolality compared to ionic agents. Iopamed is intended for parenteral administration via injection or infusion, typically utilizing an intravascular route.


How Iopamidol Enables Clear Radiological Visualization

Iopamidol's function is entirely physical, working through the principle of X-ray attenuation. The molecule contains three iodine atoms, a heavy element that acts as a dense element to temporarily block X-rays. This blockage creates a high-contrast difference, or opacification of structures, allowing blood vessels and other cavities to appear distinctly bright on the resulting image. This provides the crucial benefit of enhancing diagnostic clarity without initiating a therapeutic effect within the body.

Regulatory References

  1. Iopamidol Uses - DailyMed

What side effects are possible with Iopamed?

Possible Side Effects and Safety Information

The official safety profile of Iopamed (Iopamidol), a non-ionic contrast medium, is structured around adverse reactions classified by frequency and affected body systems, as documented in government regulatory sources. Most reactions are typically mild to moderate, transient, and self-limiting.


Frequency and System-Organ Classes

The most common adverse reactions reported in regulatory labeling include nausea, vomiting, headache, a feeling of warmth (hot flashes), and pain at the injection site . Reactions are categorized by the physiological system involved. For instance, Gastrointestinal Disorders include nausea and vomiting, while the Nervous System may present with headache or dizziness. Skin and Subcutaneous Tissue Disorders may involve flushing or hives (urticaria).


Serious Adverse Reactions and Risk Factors

Official documents highlight the risk of rare, but potentially serious adverse reactions. These include severe Anaphylactoid Reactions (life-threatening allergic-like responses) and Acute Kidney Injury (AKI), often referred to in context as contrast-associated nephropathy. Severe cardiovascular events, such as hypotension and shock, are also documented.

Safety notes specify patient groups with potentially elevated risk. Individuals with pre-existing renal impairment are at increased risk for AKI. Patients with a history of asthma or allergies have a greater susceptibility to hypersensitivity reactions. The label further notes a specific consideration for young pediatric patients, who may experience transient thyroid dysfunction following exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

The overdose profile for Iopamed focuses exclusively on the critical systemic and neurological complications that may result from high concentrations or large volumes of the non-ionic contrast agent. This information is based strictly on governmental regulatory labeling.

A primary risk of overdosage is the potential for life-threatening systemic events. These severe outcomes include primary circulatory collapse, shock, and cardiac arrest, which are documented to occur and may present without initial respiratory symptoms. Over-exposure is also associated with Acute Kidney Injury and renal failure. Furthermore, the label documents the potential for acute Central Nervous System (CNS) manifestations, such as seizures, coma, and cerebral oedema, which may occur within minutes to hours after administration.

Given the severity of these documented outcomes, regulatory authorities state that immediate medical attention must be sought when an overdose is suspected. Management is entirely supportive, with treatment directed toward the support of all vital functions and the prompt institution of symptomatic therapy. There is no specific chemical antidote documented for Iopamidol overdosage. Hospital monitoring is required, including observation for delayed haemodynamic disturbances. Patients with pre-existing renal impairment are noted to be at increased risk of dysfunction, requiring close monitoring of renal parameters.

Therapeutic Uses of Iopamed

Iopamed is commonly used across diagnostic domains where enhancing visualization is critical, generally applied in clinical settings that involve acute or unstable symptom patterns. The agent is used in supporting the assessment of conditions associated with cardiovascular, neuro-radiological, and urological disorders. This includes investigating situations presenting with symptoms that create noticeable physiological strain, like pronounced chest pain, sudden focal neurological deficits, or unexplained blood in the urine.

The diagnostic information provided by Iopamed supports the patient during difficult episodes by helping ease distress related to uncertainty. The agent assists physicians in obtaining the diagnostic certainty needed to facilitate appropriate and timely clinical action, which can ultimately help ease the patient's overall symptom load.

Quick Fact: Support for Diagnostic Clarity
Diagnostic Use Supports visualization in angiography, CT, and urography.
Symptom Context Applied for acute or disruptive symptoms like severe pain or neurological deficits.
Patient Benefit Contributes to supportive relief by assisting in the diagnostic process, supporting the formulation of focused therapeutic plans.
Primary Domain Situations involving structural issues in the heart, brain, and kidneys.

Regulatory References

  1. NIH DailyMed official Iopamidol indications

Eligibility and Restrictions for Use

Iopamed's eligibility is determined by specific regulatory criteria focused on patient health status and age. The medicine is contraindicated for patients with known hypersensitivity to iopamidol or excipients and in those with manifest hyperthyroidism. The intravascular formulation is explicitly not for intrathecal use (spinal injection).

While adults and pediatric patients are generally eligible for labeled procedures, restrictions apply. Caution is mandatory for patients with severe renal impairment or diabetes due to the risk of acute kidney injury, and for patients with congestive heart failure (who require observation). Use is restricted in patients with conditions like Multiple Myeloma, Paraproteinemia, and Sickle Cell Disease.

Age-specific rules note that children 0 to 3 years are at risk for thyroid dysfunction, requiring monitoring. For pregnancy, use is permitted only if clearly needed. A lactating woman may consider interrupting breastfeeding and discarding milk for 10 hours after administration.

These official statements structure who can and cannot use the medicine, ranging from absolute prohibitions to conditional use requiring specific precautions based on systemic and organ health.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This iodinated contrast agent has documented interactions that require specific adjustments to certain medication regimens, primarily concerning the risk of seizures and hypersensitivity reactions. The official regulatory profile prohibits or restricts concurrent use with specific categories of medicines and substances.

Interacting Product Category Interaction Requirement Contextual Note
Agents that Lower the Seizure Threshold (e.g., tricyclic antidepressants, phenothiazine derivatives, MAO inhibitors) Must be discontinued 48 hours prior to and resumed at least 24 hours after intrathecal administration. This restriction applies only when the agent is used in the spine.
Metformin Use requires caution due to the risk of contrast-induced acute kidney injury, which can lead to Metformin-associated lactic acidosis. Medical supervision is necessary to manage this risk in relevant patients.
Intrathecal Corticosteroids Contraindicated for co-administration. This combination is strictly prohibited.
Aldesleukin Requires caution due to an enhanced risk of allergic or hypersensitivity reactions. The potential for adverse reactions is increased.

Additionally, the contrast medium is physically incompatible with many other drugs and should not be admixed with any other pharmaceuticals, nor injected into intravenous lines containing other drugs, to prevent in vitro interaction.

Mechanism of Action

How Iopamed Works: Mechanism of Action

Iopamed functions through a physical contrast mechanism rather than typical receptor- or enzyme-mediated pharmacological action. The drug's primary action is the differential attenuation of X-rays, which is dependent on the high atomic number of the iodine atoms incorporated into its stable, non-ionic molecular structure.

Once administered, the drug rapidly distributes into the extracellular fluid space and the bloodstream due to its hydrophilic nature and minimal plasma protein binding. This process leads to the uniform concentration of the contrast medium within vascular and interstitial spaces. The high concentration of iodine physically absorbs a greater proportion of X-ray photons compared to surrounding soft tissue, resulting in a pronounced difference in image signal.

Following distribution, the molecule is not metabolized; the mechanism is completed by its swift and predictable removal from the body via glomerular filtration in the kidneys. This process facilitates a return of plasma and urine concentration to baseline levels, contributing to the time-limited nature of the drug's physical effects.

Dosage and Administration Information

How to Use Iopamed (Iopamidol Injection) — Administration Guidelines

Iopamed, a contrast agent, must be administered strictly according to prescribed procedures to ensure correct use. It is not a self-administered medication; its use is confined to controlled clinical settings by qualified healthcare professionals.

Administration Scope

Attribute Instruction Summary
Route of Administration Primarily administered by Intra-arterial (IA) or Intravenous (IV) injection. A separate, specific formulation (e.g., ISOVUE-M) is required for Intrathecal (spinal canal) use.
Dosing Schedule Highly individualized based on the specific diagnostic procedure (e.g., angiography, CT scan), the concentration of the product, and patient weight. Dosing rules specify the recommended volume (mL) per injection and the maximum total volume for the procedure.
Frequency Iopamed is typically a single-procedure use agent. Repeat examinations, especially those involving the intrathecal route, require a specific waiting interval, which may be up to 48 hours or longer.

Preparation and Procedural Rules

Before administration, the solution must be visually inspected for clarity, and any container showing particulate matter or discoloration must be discarded. It is recommended to warm the solution to body temperature (37 C) prior to injection to improve patient comfort.

Special Conditions:

  • Hydration: Adequate patient hydration is mandatory both before and after administration, particularly for infants, the elderly, and patients with pre-existing kidney conditions.
  • Mixing: Iopamed is a single-use, sterile product and must not be mixed with other pharmaceuticals.
  • Intrathecal Safety: The standard IV/IA solution must never be used for intrathecal administration; only the specially approved myelography formulation may be used for spinal procedures.

Connection to Usage Protocols: These instructions define a precise use protocol that governs the physical preparation of the contrast medium, the route of injection, and the maximum allowed dose, ensuring that the medicine is utilized only within established parameters.

Recent Clinical Evidence

Recent Clinical Evidence Summary

Iopamed (generic name Iopamidol) is a nonionic, low-osmolar iodinated contrast agent used in diagnostic X-ray procedures such as computed tomography (CT) scans and angiography. Clinical evidence related to Iopamed primarily focuses on its utility in enhancing image quality and its safety profile compared to other contrast media.


Key Clinical Study Findings

Research has explored the compound's effect profile as a diagnostic imaging agent. The primary goal of major studies is to measure the extent of image enhancement and the compound's tolerability.

  • Efficacy in Imaging: Studies have confirmed that Iopamed effectively increases the radiopacity of blood vessels and internal structures, aiding in the visualization required for accurate diagnosis during procedures like coronary CT angiography (CCTA) and myelography. The compound's low osmolality is a key property studied for minimizing adverse effects.

  • Comparative Safety: Large meta-analyses and randomized controlled trials (RCTs) have compared Iopamed (a low-osmolar agent) with iso-osmolar contrast media. These comparisons generally focus on patient discomfort, pain, and sensation of warmth during intra-arterial injection. Findings were mixed, with some studies showing no significant difference in warmth sensation compared to certain iso-osmolar agents.


Safety and Tolerability Profile

Safety data has been compiled across numerous clinical trials. The overall safety assessment includes a detailed review of all treatment-emergent adverse events (TEAEs).

  • Renal Function Studies: Research has investigated the risk of contrast-induced acute kidney injury (AKI), particularly in patients with pre-existing kidney issues. Studies frequently monitor serum creatinine levels to assess renal safety following administration.
  • Subgroup Analysis: Safety studies included specific populations, such as participants with mild liver impairment, to monitor the compound's profile in these groups. Severe adverse events were not observed in certain subgroups during monitored observation periods.

Emerging Research Directions

Research continues to examine the agent's impact on vulnerable populations, including very young children, where thyroid function may be monitored after procedures. The clinical significance of early observations regarding mitochondrial effects in non-clinical models remains undetermined.

Key Studies & References

  1. A comparison of pain and warmth sensation between low-osmolar and iso-osmolar contrast media during intra-arterial angiography: a systematic review

Frequently Asked Questions (FAQ)

Common questions about Iopamed (FAQ)

Q: Is Iopamed similar to other contrast dyes I've heard of?

A: Yes, Iopamed (Iopamidol) is an example of a non-ionic, low-osmolar iodinated contrast agent, which is a specific type of medium used in diagnostic imaging. Official product information confirms that it belongs to the widely used class of iodinated contrast media.


Q: How quickly does Iopamed start working after it's given?

A: Regulatory information indicates that the drug is rapidly distributed into the bloodstream. In diagnostic imaging procedures, the peak concentration required for image enhancement is typically observed within minutes after rapid injection.


Q: What are the most common side effects people report with Iopamed?

A: The most common reactions reported in clinical trials are typically mild. These include nausea, vomiting, headache, a feeling of warmth or hot flashes, and a temporary pain or burning sensation at the injection site. Regulatory documents confirm these as the most frequent adverse reactions.


Q: Does Iopamed interact with blood sugar levels?

A: Iopamed does not directly alter blood sugar levels. However, official safety information indicates that caution is necessary in patients who are taking the diabetes medication Metformin. This is due to the risk of contrast-induced acute kidney injury, which can, in turn, lead to Metformin-associated lactic acidosis.


Q: Are there any common foods or supplements that should be avoided with Iopamed?

A: Official drug information generally focuses on interactions with other medicines. There are typically no specific common foods or non-drug supplements cited in regulatory documents that must be avoided when receiving Iopamed.


Q: Is an allergic reaction to Iopamed common?

A: No. Severe allergic reactions (hypersensitivity) are classified as life-threatening or fatal but are rare. Less severe reactions, such as hives (urticaria), are reported in a small percentage of patients, with a reported frequency of 1% or less.


Q: What is the difference between Iopamed and other iodine contrast agents?

A: Iopamed contains the active ingredient Iopamidol. This chemical structure places it in the non-ionic category. Official documents classify Iopamed as a low-osmolar agent, which is a key distinction from older ionic contrast agents.


Q: What should I tell the doctor before getting Iopamed?

A: Official documentation advises that patients disclose any history of hypersensitivity to contrast media or iodine, a history of asthma or allergies, any existing kidney conditions or diabetes, and if they are currently taking Metformin.


Q: Can Iopamed interfere with thyroid function tests?

A: Yes, it can. Because Iopamed contains high concentrations of iodine, the presence of this iodine can temporarily interfere with and invalidate certain thyroid function tests. This interference may persist for several weeks following administration.


Q: Do I need to fast before a procedure using Iopamed?

A: Fasting requirements depend on the specific diagnostic procedure being performed. Official instructions for some procedures may allow a normal diet up to two hours beforehand. Adherence to the clinical site’s specific pre-procedure instructions is necessary.


Q: Why do some people feel dizzy after the Iopamed injection?

A: Dizziness is listed in the regulatory documents as a possible side effect that may affect the central nervous system after administration. However, the official label does not provide a specific physiological explanation for why this reaction occurs.


Q: What happens to the Iopamed after the scan is finished?

A: Iopamed is not broken down or metabolized by the body. Once the scan is complete, the drug is eliminated almost entirely through the kidneys via a process called glomerular filtration, typically within 24 hours in individuals with normal kidney function.


Q: Can I drive right after a procedure involving Iopamed?

A: Procedures involving Iopamed may temporarily impair the patient's ability to drive or use machinery due to potential side effects or post-procedure effects. The final decision on resuming activities like driving must be made by the healthcare professional supervising the procedure.


Q: Does Iopamed contain any shellfish or common allergens?

A: Iopamed (Iopamidol) is a synthetic chemical compound and does not contain shellfish protein. However, official warnings state that people with a known sensitivity to iodine or a general history of allergies are known to be at an increased risk for hypersensitivity reactions to the drug.


Q: What kind of studies support the use of Iopamed?

A: The use of Iopamed is supported by clinical data, including randomized controlled trials. These studies confirm its effectiveness in enhancing radiographic images and focus on evaluating its safety profile compared to other contrast media.


Q: Why is hydration important when using Iopamed?

A: Adequate hydration is mandatory both before and after receiving Iopamed. This is necessary to assist the body in eliminating the contrast medium and is a key measure for minimizing the risk of contrast-induced acute kidney injury (AKI).


Q: Can Iopamed cause skin irritation or rash?

A: Yes, skin reactions are possible. Common adverse reactions include a rash or hives (urticaria). Official safety information also notes the rare risk of developing Severe Cutaneous Adverse Reactions (SCAR), which are serious skin conditions.


Q: Is Iopamed used for MRI or only CT and X-ray?

A: Iopamed is an iodinated contrast agent, and its indications are limited to diagnostic X-ray procedures, such as angiography and CT scans. It is not indicated for use in Magnetic Resonance Imaging (MRI), which utilizes a different class of contrast agents.


Q: Why are people asked about their allergy history before using Iopamed?

A: This question is asked for risk assessment. Official warnings indicate that patients who have a history of allergies, such as asthma, allergic rhinitis, or general food allergies, are at an increased susceptibility to have a hypersensitivity reaction to the contrast agent.


Q: Why is it necessary to have a contrast agent like Iopamed for certain scans?

A: It is necessary because the iodine atoms in Iopamed physically block X-rays, creating a high-contrast difference. This opacification is essential to visualize structures like blood vessels or organs clearly, allowing the physician to obtain a more accurate diagnosis.


Q: Is there any pain associated with the administration of Iopamed?

A: Yes, regulatory documents list pain at the injection site as one of the most common adverse reactions reported after the drug is administered intravenously or intra-arterially.


Q: What are the alternatives if I cannot receive Iopamed?

A: Official labeling suggests that for some high-risk patients, Iopamed should only be used if the necessary information cannot be obtained with alternative imaging modalities. Specific alternatives are not listed in the official drug information, as decisions regarding alternative imaging must be made by the treating physician.


Q: Are there specific instructions for aftercare following a procedure with Iopamed?

A: Official documentation states that maintaining adequate hydration following the procedure is the primary aftercare consideration. This action is essential to help the body rapidly eliminate the contrast medium through the kidneys.


Q: Does Iopamed affect kidney function temporarily?

A: The drug is eliminated by the kidneys, and monitoring of renal function after the procedure may be required by healthcare professionals, especially for patients with pre-existing kidney impairment, due to the risk of acute kidney injury.


Q: Why do some people develop hives after exposure to contrast dyes like Iopamed?

A: Hives are listed as a manifestation of a hypersensitivity or allergic-like reaction. Official safety warnings indicate that this occurs when an individual's immune system responds to the contrast agent.

How should Iopamed be stored and disposed of?

How to Store and Dispose of Iopamed?

Iopamed (Iopamidol injection) must be stored and handled according to strict regulatory requirements to maintain its stability and sterility.


Storage Requirements

The product must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), and must be protected from light. It is mandatory that the solution is not frozen and remains in its original package. Before use, the solution must be visually inspected for discoloration or particulate matter, and any compromised product must be discarded. As with all medications, Iopamed must be kept out of the sight and reach of children.


Disposal Instructions

Iopamed is provided in single-dose containers, and any unused portion must be discarded immediately after the procedure. Disposal of the contents and container must be performed according to local regulations established for pharmaceutical waste. The product must not be allowed to enter sewers, surface water, or ground water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Iopamed found in:

A-Z Index: